Standard BioTools
(NASDAQ) LAB
Standard BioTools Financials at a Glance
Market Cap
$359.52MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
$86.26M
Net Income (TTM)
-$94.08M
EPS (TTM)
-$0.25
P/E Ratio
-3.75
Dividend
$0.00
Beta (Volatility)
1.48 (Average)
Dividend
$0.00
Beta (Volatility)
1.48 (Average)
Price
$0.92
Volume
1,250,815.679
Open
$0.94
Price
$0.92
Volume
1,250,815.679
Open
$0.94
Previous Close
$0.92
Daily Range
$0.90 - $0.97
52-Week Range
$0.70 - $1.72
Estimated Earnings Date
Aug 10, 2026
Dividend
$0.00
Beta (Volatility)
1.48 (Average)
Price
$0.92
Volume
1,250,815.679
Open
$0.94
Previous Close
$0.92
Daily Range
$0.90 - $0.97
52-Week Range
$0.70 - $1.72
Estimated Earnings Date
Aug 10, 2026
LAB News
Why Fluidigm Stock Plunged Today
Why Fluidigm Stock Surged Today
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Standard BioTools
Industry
Life Sciences Tools and Services
Sector
Health CareEmployees
389
CEO
Michael Egholm, PhD
Website
www.standardbio.comHeadquarters
Boston, MA 02109, US
LAB Financials
Key Financial Metrics (TTM)
Gross Margin
48.30%
Operating Margin
-91.02%
Net Income Margin
-109.08%
Return on Equity
-20.80%
Return on Capital
-20.50%
Return on Assets
-14.72%
Earnings Yield
-26.67%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$359.52MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
391.46M
Volume
1.25M
Avg. Volume
3.92M
Financials (TTM)
Gross Profit
$41.66M
Operating Income
-$78.51M
EBITDA
-$81.51M
Operating Cash Flow
-$90.66M
Capital Expenditure
-$3.82M
Free Cash Flow
-$94.48M
Cash & ST Invst.
$455.18M
Total Debt
$29.49M
Standard BioTools Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$21.15M
+4.6%
Gross Profit
$11.31M
+2.3%
Gross Margin
53.48%
N/A
Market Cap
$359.52MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$926.60K
N/A
Employees
388
N/A
Net Income
-$45.22M
-73.7%
EBITDA
-$13.21M
+31.6%
Quarterly Fundamentals
Total Cash
$455.18M
+76.4%
Total Debt
$29.49M
-6.5%
Accounts Receivable
$16.64M
-53.1%
Inventory
$18.59M
-55.9%
Long Term Debt
$23.95M
-4.9%
Short Term Debt
$5.54M
-12.5%
Return on Assets
-14.72%
N/A
Return on Invested Capital
-13.15%
N/A
Free Cash Flow
-$47.17M
-33.5%
Operating Cash Flow
-$46.60M
-53.9%